ISRCTN15395684
Recruiting
Not Applicable
Evaluation of multi-parametric magnetic resonance imaging for characterising lymph node status, peritoneal and liver metastasis in pancreatic cancer
niversity Hospitals Bristol NHS Foundation Trust0 sites30 target enrollmentNovember 29, 2017
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity Hospitals Bristol NHS Foundation Trust
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patient \= 18 years
- •2\. Confirmed or suspected pancreatic cancer referred for pancreaticoduodenectomy
- •3\. Fit for general anaesthesia
- •4\. Signed informed consent
Exclusion Criteria
- •1\. Prisoners and adults lacking capacity to consent
- •2\. Patients undergoing distal or total pancreatectomy
- •3\. Contraindications to MR (implanted electronic devices, metallic foreign bodies, claustrophobia, body weight \>140 kg or waist perimeter exceeding manufacturer‘s recommendations and others according to manufacturer’s recommendations and generally accepted guidelines)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Evaluation of ability of MRI scan in identifying muscle layer of urinary bladder in urinary bladder cancer patientsHealth Condition 1: C679- Malignant neoplasm of bladder, unspecifiedCTRI/2022/02/040206AIIMS Bhubaneswar
Recruiting
Phase 3
Evaluation of Multiparametric Magnetic Resonance Imaging and Positron Emission Tomography with a [68Ga]gallium-labelled prostate-specific membrane antigen (PSMA) ligand for the Detection of Multiple Cancer Foci in Localized Prostate Cancer Patients – A Pilot Studyocalized Prostate CancerLocalized Prostate CancerCancer - ProstateACTRN12614000783628Queensland University of Technology20
Completed
Phase 2
A study looking at the use of multiparametric Magnetic Resonance Imaging (MRI) and Positron Emission Tomography - Computed Tomography (PET-CT) to evaluate radiological changes after lung stereotactic ablative radiotherapy (SABR).on small cell lung cancer (NSCLC)Oligometastatic disease involving lungNon small cell lung cancer (NSCLC)Cancer - Lung - Non small cellCancer - Other cancer typesACTRN12616000801415iverpool Hospital23
Recruiting
Not Applicable
Multi-parametric MRI for Therapeutic Response Prediction in Rectal CancerRectal CancerCancer - Bowel - Back passage (rectum) or large bowel (colon)ACTRN12616001690448Dr Trang Pham35
Recruiting
Not Applicable
Multiparametric magnetic resonance imaging for evaluation of diffuse and focal liver diseaseK76.9Liver disease, unspecifiedDRKS00007859niversitätsklinikum Bonn1,000